<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.1d3"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">82608</article-id><article-id pub-id-type="doi">10.7554/eLife.82608</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Epidemiology and Global Health</subject></subj-group><subj-group subj-group-type="heading"><subject>Genetics and Genomics</subject></subj-group></article-categories><title-group><article-title>Polygenic risk scores for the prediction of common cancers in East Asians: A population-based prospective cohort study</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-258919"><name><surname>Ho</surname><given-names>Peh Joo</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-107442"><name><surname>Tan</surname><given-names>Iain BeeHuat</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-290421"><name><surname>Chong</surname><given-names>Dawn Qingqing</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-20576"><name><surname>Khor</surname><given-names>Chiea Chuen</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-290422"><name><surname>Yuan</surname><given-names>Jian-Min</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="par-5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-290423"><name><surname>Koh</surname><given-names>Woon-Puay</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="other" rid="par-2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-290420"><name><surname>Dorajoo</surname><given-names>Rajkumar</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-4"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" corresp="yes" id="author-80704"><name><surname>Li</surname><given-names>Jingmei</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-8587-7511</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor2">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><institution>Genome Institute of Singapore</institution>, <addr-line><named-content content-type="city">Singapore</named-content></addr-line>, <country>Singapore</country></aff><aff id="aff2"><institution content-type="dept">Division of Medical Oncology</institution>, <institution>National Cancer Centre Singapore</institution>, <addr-line><named-content content-type="city">Singapore</named-content></addr-line>, <country>Singapore</country></aff><aff id="aff3"><institution>UPMC Hillman Cancer Center</institution>, <addr-line><named-content content-type="city">Pittsburgh</named-content></addr-line>, <country>United States</country></aff><aff id="aff4"><institution content-type="dept">Yong Loo Lin School of Medicine</institution>, <institution>National University of Singapore</institution>, <addr-line><named-content content-type="city">Singapore</named-content></addr-line>, <country>Singapore</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-156275"><name><surname>Yang</surname><given-names>Qifeng</given-names></name><role>Reviewing editor</role><aff><institution>Qilu Hospital of Shandong University</institution>, <country>China</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>dorajoor@gis.a-star.edu.sg</email> (RD);</corresp><corresp id="cor2"><label>*</label>For correspondence: <email>lijm1@gis.a-star.edu.sg</email> (JL);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>27</day><month>03</month><year>2023</year></pub-date><volume>12</volume><elocation-id>e82608</elocation-id><history><date date-type="received"><day>10</day><month>08</month><year>2022</year></date><date date-type="accepted"><day>24</day><month>03</month><year>2023</year></date></history><permissions><copyright-statement>Â© 2023, Ho et al</copyright-statement><copyright-year>2023</copyright-year><copyright-holder>Ho et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-82608-v1.pdf"/><abstract><p><bold>Background:</bold> To evaluate the utility of polygenic risk scores (PRS) in identifying high-risk individuals, different publicly available PRS for breast (n=85), prostate (n=37), colorectal (n=22) and lung cancers (n=11) were examined in a prospective study of 21,694 Chinese adults.</p><p><bold>Methods:</bold> We constructed PRS using weights curated in the online PGS Catalog. PRS performance was evaluated by distribution, discrimination, predictive ability, and calibration. Hazard ratios (HR) and corresponding confidence intervals [CI] of the common cancers after 20 years of follow-up were estimated using Cox proportional hazard models for different levels of PRS.</p><p><bold>Results:</bold> A total of 495 breast, 308 prostate, 332 female-colorectal, 409 male-colorectal, 181 female-lung and 381 male-lung incident cancers were identified. The area under receiver operating characteristic curve for the best performing site-specific PRS were 0.61 (PGS000873, breast), 0.70 (PGS00662, prostate), 0.65 (PGS000055, female-colorectal), 0.60 (PGS000734, male-colorectal) and 0.56 (PGS000721, female-lung), and 0.58 (PGS000070, male-lung), respectively. Compared to the middle quintile, individuals in the highest cancer-specific PRS quintile were 64% more likely to develop cancers of the breast, prostate, and colorectal. For lung cancer, the lowest cancer-specific PRS quintile was associated with 28-34% decreased risk compared to the middle quintile. In contrast, the hazard ratios observed for quintiles 4 (female-lung: 0.95 [0.61-1.47]; male-lung: 1.14 [0.82-1.57]) and 5 (female-lung: 0.95 [0.61-1.47]) were not significantly different from that for the middle quintile.</p><p><bold>Conclusions:</bold> Site-specific PRSs can stratify the risk of developing breast, prostate, and colorectal cancers in this East Asian population. Appropriate correction factors may be required to improve calibration.</p><p><bold>Funding</bold> This work is supported by the National Research Foundation Singapore (NRF-NRFF2017-02), PRECISION Health Research, Singapore (PRECISE) and the Agency for Science, Technology and Research (A*STAR). WP Koh was supported by National Medical Research Council, Singapore (NMRC/CSA/0055/2013). CC Khor was supported by National Research Foundation Singapore (NRF-NRFI2018-01). Rajkumar Dorajoo received a grant from the Agency for Science, Technology and Research Career Development Award (A*STAR CDA - 202D8090), and from Ministry of Health Healthy Longevity Catalyst Award (HLCA20Jan-0022). The Singapore Chinese Health Study was supported by grants from the National Medical Research Council, Singapore (NMRC/CIRG/1456/2016) and the U.S. National Institutes of Health [NIH] (R01 CA144034 and UM1 CA182876).</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>None</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001381</institution-id><institution>National Research Foundation Singapore</institution></institution-wrap></funding-source><award-id>PRECISE</award-id><principal-award-recipient><name><surname>Li</surname><given-names>Jingmei</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001349</institution-id><institution>National Medical Research Council</institution></institution-wrap></funding-source><award-id>NMRC/CSA/0055/2013</award-id><principal-award-recipient><name><surname>Koh</surname><given-names>Woon-Puay</given-names></name></principal-award-recipient></award-group><award-group id="par-3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001381</institution-id><institution>National Research Foundation Singapore</institution></institution-wrap></funding-source><award-id>NRF-NRFI2018-01</award-id><principal-award-recipient><name><surname>Khor</surname><given-names>Chiea Chuen</given-names></name></principal-award-recipient></award-group><award-group id="par-4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001350</institution-id><institution>Ministry of Health -Singapore</institution></institution-wrap></funding-source><award-id>HLCA20Jan-0022</award-id><principal-award-recipient><name><surname>Dorajoo</surname><given-names>Rajkumar</given-names></name></principal-award-recipient></award-group><award-group id="par-5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>R01 CA144034 and UM1 CA182876</award-id><principal-award-recipient><name><surname>Yuan</surname><given-names>Jian-Min</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf2"><p>Rajkumar Dorajoo, received a grant from the Agency for Science, Technology and Research Career Development Award (A*STAR CDA - 202D8090, and from Ministry of Health Healthy Longevity Catalyst Award (HLCA20Jan-0022). The author has no other competing interests to declare..</p></fn><fn fn-type="conflict" id="conf1"><p>The other authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Human subjects: The study was approved by the Institutional Review Boards of the National University of Singapore, University of Pittsburgh, and the Agency for Science, Technology and Research (A*STAR, reference number 2022-042). Written, informed consent was obtained from all study participants.</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>All polygenic risk scores used in this study are publicly available in the PGS Catalog (https://www.pgscatalog.org).The data that support the findings of our study are available from the corresponding authors of the study upon reasonable request (Dr Rajkumar s/o Dorajoo, dorajoor@gis.a-star.edu.sg and Dr Jingmei Li, lijm1@gis.a-star.edu.sg). More information regarding the data access to SCHS can be found at: https://sph.nus.edu.sg/research/cohort-schs/. The data are not publicly available due to Singapore laws.Source Data 1 contain the numerical data used to generate the figure 1.The code for the study is uploaded as Source Code 1.</p><p>The following previously published datasets were used:</p><p><element-citation id="dataset1" publication-type="data" specific-use="references"><person-group person-group-type="author"><collab>Samuel A Lambert</collab><collab>Laurent Gil</collab><collab>Simon Jupp</collab><collab>Scott C Ritchie</collab><collab>Yu Xu</collab><collab>Annalisa Buniello</collab><collab>Aoife McMahon</collab><collab>Gad Abraham</collab><collab>Michael Chapman</collab><collab>Helen Parkinson</collab><collab>John Danesh</collab><collab>Jacqueline AL MacArthur and Michael Inouye</collab></person-group><year iso-8601-date="2021">2021</year><source>The Polygenic Score Catalog as an open database for reproducibility and systematic evaluation</source><ext-link ext-link-type="uri" xlink:href="https://www.pgscatalog.org/">https://www.pgscatalog.org/</ext-link><comment>PGS Catalog</comment></element-citation></p></sec><supplementary-material><ext-link xlink:href="elife-82608-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>